Skip to main content

Advertisement

Log in

A novel long-range deletion spanning STX16 and NPEPL1 causing imprinting defects of the GNAS locus discovered in a patient with autosomal-dominant pseudohypoparathyroidism type 1B

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

Pseudohypoparathyroidism (PHP) is a rare disorder characterized by hypocalcemia, hyperphosphatemia, and resistance to parathyroid hormone (PTH). According to different GNAS mutations, PHP is divided into several subtypes, among which autosomal-dominant PHP1B (AD-PHP1B) is caused by STX16 deletion and epigenetic alteration of GNAS. Although the deletion of STX16 exons 2−6 is commonly observed, other mutations involving STX16 can also result in AD-PHP1B.

Materials and methods

The clinical information of a 38-year-old male PHP patient was collected. The genomic DNA from peripheral blood cells was extracted for genetic analysis of GNAS and upstream STX16 by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) and whole-exome sequencing (WES). Sanger sequencing was performed to verify the break point of the novel long-range deletion.

Results

The patient’s medical history of tetany and seizure as well as laboratory examination showing hypocalcemia and elevated PTH levels indicated the diagnosis of PHP. The results of MS-MLPA showed loss of methylation of GNAS A/B:TSS-DMR and half-reduced copy number of STX16 exon 1−9, which revealed the subtype of AD-PHP1B. Furthermore, the WES study displayed a 87.5 kb missing upstream of GNAS. A 87.5 kb deletion spanning STX16 and NPEPL1 together with an insertion of 28 bp of unknown origin was verified by PCR along with Sanger sequencing.

Conclusions

A novel deletion of 87.5 kb spanning STX16 and NPEPL1 was discovered in an AD-PHP1B patient, which provides new information on molecular defects leading to AD-PHP1B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. G. Mantovani, M. Bastepe, D. Monk, L. de Sanctis, S. Thiele, A. Usardi et al., Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat. Rev. Endocrinol. 14(8), 476–500 (2018). https://doi.org/10.1038/s41574-018-0042-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. A. Nakamura, E. Hamaguchi, R. Horikawa, Y. Nishimura, K. Matsubara, S. Sano et al., Complex genomic rearrangement within the GNAS region associated with familial pseudohypoparathyroidism type 1b. J. Clin. Endocrinol. Metab. 101(7), 2623–2627 (2016). https://doi.org/10.1210/jc.2016-1725

    Article  CAS  PubMed  Google Scholar 

  3. L. Akin, S. Kurtoglu, A. Yildiz, M.A. Akin, M. Kendirici, Vitamin D deficiency rickets mimicking pseudohypoparathyroidism. J. Clin. Res. Pediatr. Endocrinol. 2(4), 173–175 (2010). https://doi.org/10.4274/jcrpe.v2i4.173

    Article  PubMed  PubMed Central  Google Scholar 

  4. M.A. Levine, An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 19(6), 443–451 (2012). https://doi.org/10.1097/MED.0b013e32835a255c

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. F.M. Elli, L. de Sanctis, E. Peverelli, P. Bordogna, B. Pivetta, G. Miolo et al., Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR. J. Clin. Endocrinol. Metab. 99(4), E724–E728 (2014). https://doi.org/10.1210/jc.2013-3704

    Article  CAS  PubMed  Google Scholar 

  6. M. Bastepe, J.E. Pincus, T. Sugimoto, K. Tojo, M. Kanatani, Y. Azuma et al., Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum. Mol. Genet. 10(12), 1231–1241 (2001). https://doi.org/10.1093/hmg/10.12.1231

    Article  CAS  PubMed  Google Scholar 

  7. N. Richard, G. Abeguile, N. Coudray, H. Mittre, N. Gruchy, J. Andrieux et al., A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J. Clin. Endocrinol. Metab. 97(5), E863–E867 (2012). https://doi.org/10.1210/jc.2011-2804

    Article  CAS  PubMed  Google Scholar 

  8. A. Linglart, R.C. Gensure, R.C. Olney, H. Juppner, M. Bastepe, A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am. J. Hum. Genet. 76(5), 804–814 (2005). https://doi.org/10.1086/429932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. M. Bastepe, L.F. Frohlich, A. Linglart, H.S. Abu-Zahra, K. Tojo, L.M. Ward et al., Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat. Genet. 37(1), 25–27 (2005). https://doi.org/10.1038/ng1487

    Article  CAS  PubMed  Google Scholar 

  10. T. Eggermann, G. Perez de Nanclares, E.R. Maher, I.K. Temple, Z. Tumer, D. Monk et al., Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin. Epigenetics 7, 123 2015). https://doi.org/10.1186/s13148-015-0143-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. M. Bastepe, A.H. Lane, H. Juppner, Paternal uniparental isodisomy of chromosome 20q-and the resulting changes in GNAS1 methylation-as a plausible cause of pseudohypoparathyroidism. Am. J. Hum. Genet. 68(5), 1283–1289 (2001). https://doi.org/10.1086/320117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. S. Turan, J. Ignatius, J.S. Moilanen, O. Kuismin, H. Stewart, N.P. Mann et al., De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases. J. Clin. Endocrinol. Metab. 97(12), E2314–E2319 (2012). https://doi.org/10.1210/jc.2012-2920

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. P.J. Wittkopp, G. Kalay, Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence. Nat. Rev. Genet. 13(1), 59–69 (2011). https://doi.org/10.1038/nrg3095

    Article  CAS  PubMed  Google Scholar 

  14. H. Neto, A. Kaupisch, L.L. Collins, G.W. Gould, Syntaxin 16 is a master recruitment factor for cytokinesis. Mol. Biol. Cell 24(23), 3663–3674 (2013). https://doi.org/10.1091/mbc.E13-06-0302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. G. Kang, H. Yun, C.H. Sun, I. Park, S. Lee, J. Kwon et al., Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors. Oncotarget 7(6), 6538–6551 (2016). https://doi.org/10.18632/oncotarget.3731

    Article  PubMed  Google Scholar 

  16. M. Bastepe, H. Juppner, GNAS locus and pseudohypoparathyroidism. Horm. Res. 63(2), 65–74 (2005). https://doi.org/10.1159/000083895

    Article  CAS  PubMed  Google Scholar 

  17. X. Chu, Y. Zhu, O. Wang, M. Nie, T. Quan, Y. Xue et al., Clinical and genetic characteristics of pseudohypoparathyroidism in the Chinese population. Clin. Endocrinol. 88(2), 285–294 (2018). https://doi.org/10.1111/cen.13516

    Article  CAS  Google Scholar 

  18. Z. Coban-Akdemir, J.J. White, X. Song, S.N. Jhangiani, J.M. Fatih, T. Gambin et al., Identifying genes whose mutant transcripts cause dominant disease traits by potential gain-of-function alleles. Am. J. Hum. Genet. 103(2), 171–187 (2018). https://doi.org/10.1016/j.ajhg.2018.06.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. I.M. de Lange, A.A. Verrijn Stuart, R.B. van der Luijt, H.K. Ploos van Amstel, M.M. van Haelst, Macrosomia, obesity, and macrocephaly as first clinical presentation of PHP1b caused by STX16 deletion. Am. J. Med. Genet. A 170(9), 2431–2435 (2016). https://doi.org/10.1002/ajmg.a.37818

    Article  CAS  PubMed  Google Scholar 

  20. E. Fernandez-Rebollo, B. Lecumberri, I. Garin, J. Arroyo, A. Bernal-Chico, F. Goni et al., New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur. J. Endocrinol. 163(6), 953–962 (2010). https://doi.org/10.1530/eje-10-0435

    Article  CAS  PubMed  Google Scholar 

  21. R. Guerreiro, J. Bras, S. Batista, P. Pires, M.H. Ribeiro, M.R. Almeida et al., Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation. Genes Brain Behav. 15(7), 669–677 (2016). https://doi.org/10.1111/gbb.12308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. L.F. Fröhlich, M. Mrakovcic, R. Steinborn, U.-I. Chung, M. Bastepe, H. Juppner, Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib. PNAS 107(20), 9275–9280 (2010)

    Article  Google Scholar 

  23. A. Linglart, M. Bastepe, H. Juppner, Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin. Endocrinol. 67(6), 822–831 (2007). https://doi.org/10.1111/j.1365-2265.2007.02969.x

    Article  CAS  Google Scholar 

  24. A. Linglart, S. Maupetit-Mehouas, C. Silve, GNAS-related loss-of-function disorders and the role of imprinting. Horm. Res. Paediatr. 79(3), 119–129 (2013). https://doi.org/10.1159/000348516

    Article  CAS  PubMed  Google Scholar 

  25. S. Mulchandani, E.J. Bhoj, M. Luo, N. Powell-Hamilton, K. Jenny, K.W. Gripp et al., Maternal uniparental disomy of chromosome 20: a novel imprinting disorder of growth failure. Genet. Med. 18(4), 309–315 (2016). https://doi.org/10.1038/gim.2015.103

    Article  CAS  PubMed  Google Scholar 

  26. F.I. Rezwan, R.L. Poole, T. Prescott, J.M. Walker, I. Karen Temple, D.J. Mackay, Very small deletions within the NESP55 gene in pseudohypoparathyroidism type 1b. Eur. J. Hum. Genet. 23(4), 494–499 (2015). https://doi.org/10.1038/ejhg.2014.133

    Article  CAS  PubMed  Google Scholar 

  27. Y. Wang, M. Nie, O. Wang, Y. Li, Y. Jiang, M. Li et al., Genetic screening in a large Chinese cohort of childhood onset hypoparathyroidism by next-generation sequencing combined with TBX1-MLPA. J. Bone Miner. Res. (2019). https://doi.org/10.1002/jbmr.3854

  28. C.M. Williamson, S.T. Ball, W.T. Nottingham, J.A. Skinner, A. Plagge, M.D. Turner et al., A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas. Nat. Genet. 36(8), 894–899 (2004). https://doi.org/10.1038/ng1398

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patient for getting permission to publish relative information.

Funding

This work was supported by the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (CAMS-I2M) (No. 2017-I2M-1–001) and the National Natural Science Foundation of China (No. 81873641).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ou Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All of the procedures performed in the study involving the human participant were approved by the Ethics Committee of Peking Union Medical College Hospital and conducted under the instructions of the principles in the Declaration of Helsinki.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Chu, X., Nie, M. et al. A novel long-range deletion spanning STX16 and NPEPL1 causing imprinting defects of the GNAS locus discovered in a patient with autosomal-dominant pseudohypoparathyroidism type 1B. Endocrine 69, 212–219 (2020). https://doi.org/10.1007/s12020-020-02304-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02304-6

Keywords

Navigation